Fluent Financial’s GSK GSK Stock Holding History

Fluent Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-33,520	Closed	-$66K	–	58
2020 Q1	$66K	Buy	+33,520	New	+$1.79M	0.05%	57

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Fluent Financial's GSK Position: Q4 2020 in Review

Fluent Financial sold out of GSK (GSK) in Q4 2020, closing a stake of 75,602 shares — an estimated $3.56M sold.

Fluent Financial first reported a position in GSK in Q4 2017 and held it in 12 quarters. The position peaked at $3.71M in Q2 2020. 819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Fluent Financial reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Fluent Financial sold 75,602 GSK shares in Q4 2020, an estimated $3.56M.
Fluent Financial first reported a position in GSK in Q4 2017 and held it in 12 quarters.
Fluent Financial's GSK position peaked at $3.71M in Q2 2020.
819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Fluent Financial's 13F filing for Q4 2020, filed 22 Jan 2021.